Go Pro

Aehr Test Systems (AEHR) Competitors

Aehr Test Systems logo
$98.78 -11.11 (-10.11%)
Closing price 04:00 PM Eastern
Extended Trading
$99.65 +0.87 (+0.88%)
As of 06:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AEHR vs. BIO.B, AVTR, RAL, CAMT, and ST

Should you buy Aehr Test Systems stock or one of its competitors? MarketBeat compares Aehr Test Systems with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aehr Test Systems include Bio-Rad Laboratories (BIO.B), Avantor (AVTR), Ralliant (RAL), Camtek (CAMT), and Sensata Technologies (ST).

How does Aehr Test Systems compare to Bio-Rad Laboratories?

Bio-Rad Laboratories (NYSE:BIO.B) and Aehr Test Systems (NASDAQ:AEHR) are related mid-cap companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

0.0% of Bio-Rad Laboratories shares are owned by institutional investors. Comparatively, 69.7% of Aehr Test Systems shares are owned by institutional investors. 28.4% of Bio-Rad Laboratories shares are owned by company insiders. Comparatively, 6.8% of Aehr Test Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Aehr Test Systems had 12 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 12 mentions for Aehr Test Systems and 0 mentions for Bio-Rad Laboratories. Aehr Test Systems' average media sentiment score of 0.55 beat Bio-Rad Laboratories' score of 0.00 indicating that Aehr Test Systems is being referred to more favorably in the news media.

Company Overall Sentiment
Bio-Rad Laboratories Neutral
Aehr Test Systems Positive

Bio-Rad Laboratories has a beta of 0.93, suggesting that its stock price is 7% less volatile than the broader market. Comparatively, Aehr Test Systems has a beta of 3.1, suggesting that its stock price is 210% more volatile than the broader market.

Aehr Test Systems has a consensus price target of $117.50, suggesting a potential upside of 18.95%. Given Aehr Test Systems' stronger consensus rating and higher probable upside, analysts clearly believe Aehr Test Systems is more favorable than Bio-Rad Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bio-Rad Laboratories
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aehr Test Systems
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.00

Bio-Rad Laboratories has a net margin of 6.52% compared to Aehr Test Systems' net margin of -14.25%. Bio-Rad Laboratories' return on equity of 3.56% beat Aehr Test Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Bio-Rad Laboratories6.52% 3.56% 2.49%
Aehr Test Systems -14.25%-3.83%-3.36%

Bio-Rad Laboratories has higher revenue and earnings than Aehr Test Systems. Aehr Test Systems is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Rad Laboratories$2.58B3.49$759.90M$6.0755.52
Aehr Test Systems$50M64.44-$7.13M-$0.24N/A

Summary

Aehr Test Systems beats Bio-Rad Laboratories on 9 of the 17 factors compared between the two stocks.

How does Aehr Test Systems compare to Avantor?

Aehr Test Systems (NASDAQ:AEHR) and Avantor (NYSE:AVTR) are related mid-cap companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations and earnings.

Aehr Test Systems presently has a consensus price target of $117.50, indicating a potential upside of 18.95%. Avantor has a consensus price target of $12.00, indicating a potential downside of 10.29%. Given Aehr Test Systems' stronger consensus rating and higher probable upside, analysts plainly believe Aehr Test Systems is more favorable than Avantor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aehr Test Systems
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.00
Avantor
1 Sell rating(s)
15 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.06

69.7% of Aehr Test Systems shares are held by institutional investors. Comparatively, 95.1% of Avantor shares are held by institutional investors. 6.8% of Aehr Test Systems shares are held by insiders. Comparatively, 0.3% of Avantor shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Avantor had 13 more articles in the media than Aehr Test Systems. MarketBeat recorded 25 mentions for Avantor and 12 mentions for Aehr Test Systems. Avantor's average media sentiment score of 0.85 beat Aehr Test Systems' score of 0.55 indicating that Avantor is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aehr Test Systems
5 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Avantor
11 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Aehr Test Systems has a beta of 3.1, indicating that its share price is 210% more volatile than the broader market. Comparatively, Avantor has a beta of 0.89, indicating that its share price is 11% less volatile than the broader market.

Aehr Test Systems has higher earnings, but lower revenue than Avantor. Aehr Test Systems is trading at a lower price-to-earnings ratio than Avantor, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aehr Test Systems$50M64.44-$7.13M-$0.24N/A
Avantor$6.55B1.38-$530.20M-$0.84N/A

Avantor has a net margin of -8.81% compared to Aehr Test Systems' net margin of -14.25%. Avantor's return on equity of 9.92% beat Aehr Test Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Aehr Test Systems-14.25% -3.83% -3.36%
Avantor -8.81%9.92%4.75%

Summary

Aehr Test Systems beats Avantor on 9 of the 17 factors compared between the two stocks.

How does Aehr Test Systems compare to Ralliant?

Ralliant (NYSE:RAL) and Aehr Test Systems (NASDAQ:AEHR) are both mid-cap technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, media sentiment, profitability, valuation and analyst recommendations.

Ralliant has a beta of 1.6, indicating that its share price is 60% more volatile than the broader market. Comparatively, Aehr Test Systems has a beta of 3.1, indicating that its share price is 210% more volatile than the broader market.

Aehr Test Systems has lower revenue, but higher earnings than Ralliant. Aehr Test Systems is trading at a lower price-to-earnings ratio than Ralliant, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ralliant$2.07B3.55-$1.22B-$10.85N/A
Aehr Test Systems$50M64.44-$7.13M-$0.24N/A

69.7% of Aehr Test Systems shares are owned by institutional investors. 0.4% of Ralliant shares are owned by company insiders. Comparatively, 6.8% of Aehr Test Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Ralliant had 18 more articles in the media than Aehr Test Systems. MarketBeat recorded 30 mentions for Ralliant and 12 mentions for Aehr Test Systems. Ralliant's average media sentiment score of 0.75 beat Aehr Test Systems' score of 0.55 indicating that Ralliant is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ralliant
9 Very Positive mention(s)
2 Positive mention(s)
12 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Aehr Test Systems
5 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Ralliant currently has a consensus price target of $75.70, suggesting a potential upside of 14.05%. Aehr Test Systems has a consensus price target of $117.50, suggesting a potential upside of 18.95%. Given Aehr Test Systems' stronger consensus rating and higher possible upside, analysts clearly believe Aehr Test Systems is more favorable than Ralliant.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ralliant
1 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.67
Aehr Test Systems
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.00

Aehr Test Systems has a net margin of -14.25% compared to Ralliant's net margin of -56.38%. Ralliant's return on equity of 14.97% beat Aehr Test Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Ralliant-56.38% 14.97% 6.99%
Aehr Test Systems -14.25%-3.83%-3.36%

Summary

Aehr Test Systems beats Ralliant on 10 of the 17 factors compared between the two stocks.

How does Aehr Test Systems compare to Camtek?

Aehr Test Systems (NASDAQ:AEHR) and Camtek (NASDAQ:CAMT) are both mid-cap technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

69.7% of Aehr Test Systems shares are owned by institutional investors. Comparatively, 41.9% of Camtek shares are owned by institutional investors. 6.8% of Aehr Test Systems shares are owned by company insiders. Comparatively, 79.4% of Camtek shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Camtek has higher revenue and earnings than Aehr Test Systems. Aehr Test Systems is trading at a lower price-to-earnings ratio than Camtek, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aehr Test Systems$50M64.44-$7.13M-$0.24N/A
Camtek$496.07M13.88$50.72M$0.87169.66

In the previous week, Aehr Test Systems had 5 more articles in the media than Camtek. MarketBeat recorded 12 mentions for Aehr Test Systems and 7 mentions for Camtek. Camtek's average media sentiment score of 0.77 beat Aehr Test Systems' score of 0.55 indicating that Camtek is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aehr Test Systems
5 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Camtek
4 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Aehr Test Systems has a beta of 3.1, indicating that its share price is 210% more volatile than the broader market. Comparatively, Camtek has a beta of 1.58, indicating that its share price is 58% more volatile than the broader market.

Aehr Test Systems presently has a consensus price target of $117.50, suggesting a potential upside of 18.95%. Camtek has a consensus price target of $174.67, suggesting a potential upside of 18.34%. Given Aehr Test Systems' stronger consensus rating and higher possible upside, equities analysts clearly believe Aehr Test Systems is more favorable than Camtek.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aehr Test Systems
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.00
Camtek
0 Sell rating(s)
7 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.50

Camtek has a net margin of 9.63% compared to Aehr Test Systems' net margin of -14.25%. Camtek's return on equity of 22.26% beat Aehr Test Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Aehr Test Systems-14.25% -3.83% -3.36%
Camtek 9.63%22.26%11.70%

Summary

Camtek beats Aehr Test Systems on 10 of the 17 factors compared between the two stocks.

How does Aehr Test Systems compare to Sensata Technologies?

Sensata Technologies (NYSE:ST) and Aehr Test Systems (NASDAQ:AEHR) are related mid-cap companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

In the previous week, Sensata Technologies had 4 more articles in the media than Aehr Test Systems. MarketBeat recorded 16 mentions for Sensata Technologies and 12 mentions for Aehr Test Systems. Sensata Technologies' average media sentiment score of 0.81 beat Aehr Test Systems' score of 0.55 indicating that Sensata Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sensata Technologies
5 Very Positive mention(s)
4 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Aehr Test Systems
5 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Sensata Technologies currently has a consensus price target of $49.10, suggesting a potential upside of 3.08%. Aehr Test Systems has a consensus price target of $117.50, suggesting a potential upside of 18.95%. Given Aehr Test Systems' stronger consensus rating and higher probable upside, analysts clearly believe Aehr Test Systems is more favorable than Sensata Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sensata Technologies
1 Sell rating(s)
5 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.30
Aehr Test Systems
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.00

99.4% of Sensata Technologies shares are held by institutional investors. Comparatively, 69.7% of Aehr Test Systems shares are held by institutional investors. 0.7% of Sensata Technologies shares are held by company insiders. Comparatively, 6.8% of Aehr Test Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Sensata Technologies has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market. Comparatively, Aehr Test Systems has a beta of 3.1, meaning that its stock price is 210% more volatile than the broader market.

Sensata Technologies has a net margin of 2.37% compared to Aehr Test Systems' net margin of -14.25%. Sensata Technologies' return on equity of 18.68% beat Aehr Test Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Sensata Technologies2.37% 18.68% 7.77%
Aehr Test Systems -14.25%-3.83%-3.36%

Sensata Technologies has higher revenue and earnings than Aehr Test Systems. Aehr Test Systems is trading at a lower price-to-earnings ratio than Sensata Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sensata Technologies$3.70B1.87$31.30M$0.6079.39
Aehr Test Systems$50M64.44-$7.13M-$0.24N/A

Summary

Sensata Technologies beats Aehr Test Systems on 11 of the 17 factors compared between the two stocks.

Get Aehr Test Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for AEHR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AEHR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AEHR vs. The Competition

MetricAehr Test SystemsSemiconductors & Semiconductor Equipment IndustryTechnology SectorNASDAQ Exchange
Market Cap$3.22B$103.41B$29.54B$12.86B
Dividend YieldN/A1.57%2.76%10.00%
P/E Ratio-411.5794.0681.5725.41
Price / Sales64.4491.98597.2690.78
Price / CashN/A63.5747.9049.40
Price / Book14.1510.739.226.08
Net Income-$7.13M$1.86B$662.75M$348.07M
7 Day Performance51.04%13.81%6.85%4.71%
1 Month Performance41.19%-7.49%-1.15%-2.12%
1 Year Performance434.52%117.91%151.72%20.58%

Aehr Test Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AEHR
Aehr Test Systems
4.0165 of 5 stars
$98.78
-10.1%
$117.50
+19.0%
+477.5%$3.22B$50MN/A90
BIO.B
Bio-Rad Laboratories
N/A$309.37
flat
N/A+36.4%$8.28B$2.58B50.978,200
AVTR
Avantor
1.8518 of 5 stars
$11.80
+3.1%
$10.63
-9.9%
+20.2%$7.81B$6.55BN/A13,500
RAL
Ralliant
2.9057 of 5 stars
$69.75
+0.5%
$73.00
+4.7%
+55.9%$7.77B$2.12BN/A7,000
CAMT
Camtek
4.1572 of 5 stars
$151.46
+2.5%
$174.67
+15.3%
+56.7%$6.90B$496.07M174.09400

Related Companies and Tools


This page (NASDAQ:AEHR) was last updated on 8/5/2026 by MarketBeat.com Staff.
From Our Partners